103 related articles for article (PubMed ID: 15696928)
1. [Mechanism of mono-hydroxylation of daidzein in human liver microsomes].
Peng WX; Li HD; Zhou HH
Yao Xue Xue Bao; 2004 Nov; 39(11):892-6. PubMed ID: 15696928
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
[TBL] [Abstract][Full Text] [Related]
3. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
4. Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones.
Hu M; Krausz K; Chen J; Ge X; Li J; Gelboin HL; Gonzalez FJ
Drug Metab Dispos; 2003 Jul; 31(7):924-31. PubMed ID: 12814970
[TBL] [Abstract][Full Text] [Related]
5. Theophylline metabolism in human liver microsomes: inhibition studies.
Tjia JF; Colbert J; Back DJ
J Pharmacol Exp Ther; 1996 Mar; 276(3):912-7. PubMed ID: 8786569
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.
Kim H; Yoon YJ; Kim H; Kang S; Cheon HG; Yoo SE; Shin JG; Liu KH
Toxicol Lett; 2006 Oct; 166(2):105-14. PubMed ID: 16857327
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity.
Atherton KM; Mutch E; Ford D
Biochem Pharmacol; 2006 Aug; 72(5):624-31. PubMed ID: 16814747
[TBL] [Abstract][Full Text] [Related]
8. Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro.
Wynalda MA; Hauer MJ; Wienkers LC
Drug Metab Dispos; 1998 Oct; 26(10):1048-51. PubMed ID: 9763414
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
[TBL] [Abstract][Full Text] [Related]
10. Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
Machinist JM; Mayer MD; Shet MS; Ferrero JL; Rodrigues AD
Drug Metab Dispos; 1995 Oct; 23(10):1163-74. PubMed ID: 8654206
[TBL] [Abstract][Full Text] [Related]
11. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine.
Agúndez JA; Gallardo L; Martínez C; Gervasini G; Benítez J
Pharmacogenetics; 1998 Jun; 8(3):251-8. PubMed ID: 9682270
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
[TBL] [Abstract][Full Text] [Related]
13. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
Cribb AE; Knight MJ; Dryer D; Guernsey J; Hender K; Tesch M; Saleh TM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):551-8. PubMed ID: 16537715
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate.
Racha JK; Rettie AE; Kunze KL
Biochemistry; 1998 May; 37(20):7407-19. PubMed ID: 9585555
[TBL] [Abstract][Full Text] [Related]
15. Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
Fuhr U; Kober S; Zaigler M; Mutschler E; Spahn-Langguth H
Int J Clin Pharmacol Ther; 2005 Jul; 43(7):327-34. PubMed ID: 16035375
[TBL] [Abstract][Full Text] [Related]
16. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
Baranczewski P; Edlund PO; Postlind H
J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
[TBL] [Abstract][Full Text] [Related]
18. [O-ethyl 14C]phenacetin O-deethylase activity in human liver microsomes.
Rodrigues AD; Surber BW; Yao Y; Wong SL; Roberts EM
Drug Metab Dispos; 1997 Sep; 25(9):1097-100. PubMed ID: 9311627
[TBL] [Abstract][Full Text] [Related]
19. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
20. Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes.
Springer D; Paul LD; Staack RF; Kraemer T; Maurer HH
Drug Metab Dispos; 2003 Aug; 31(8):979-82. PubMed ID: 12867484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
